These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11814582)

  • 21. Human infectivity trait in Trypanosoma brucei: stability, heritability and relationship to sra expression.
    Turner CM; McLellan S; Lindergard LA; Bisoni L; Tait A; MacLeod A
    Parasitology; 2004 Oct; 129(Pt 4):445-54. PubMed ID: 15521633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an acute-phase reactant in murine infections with Trypanosoma brucei.
    Shapiro SZ; Black SJ
    Infect Immun; 1992 Sep; 60(9):3921-4. PubMed ID: 1500201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human innate immunity against African trypanosomes.
    Pays E; Vanhollebeke B
    Curr Opin Immunol; 2009 Oct; 21(5):493-8. PubMed ID: 19559585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein.
    Harrington JM; Howell S; Hajduk SL
    J Biol Chem; 2009 May; 284(20):13505-13512. PubMed ID: 19324878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular dialogue between African trypanosomes and humans].
    Pays E
    Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill.
    Vanhollebeke B; Pays E
    Mol Microbiol; 2010 May; 76(4):806-14. PubMed ID: 20398209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haptoglobin-related protein and apolipoprotein AI are components of the two trypanolytic factors in human serum.
    Tomlinson S; Muranjan M; Nussenzweig V; Raper J
    Mol Biochem Parasitol; 1997 May; 86(1):117-20. PubMed ID: 9178275
    [No Abstract]   [Full Text] [Related]  

  • 28. The trypanolytic factor of human serum.
    Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
    Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to monomorphic Trypanosoma brucei: humoral response.
    Zahalsky AC; Weinberg RL
    J Parasitol; 1976 Feb; 62(1):15-9. PubMed ID: 1255367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of immunity in rodents receiving living drug-treated trypanosomes.
    James DM
    Int J Parasitol; 1976 Apr; 6(2):179-82. PubMed ID: 1262128
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum.
    Smith AB; Hajduk SL
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10262-6. PubMed ID: 7479764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The trypanolytic factor-mechanism, impacts and applications.
    Wheeler RJ
    Trends Parasitol; 2010 Sep; 26(9):457-64. PubMed ID: 20646962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary bacterial infection in plasma endotoxin levels and the acute-phase response of mice infected with Trypanosoma brucei brucei.
    Ngure R; Burke J; Eckersall PD; Jennings FW; Mbai FN; Murray M
    Parasite Immunol; 2009 Jul; 31(7):357-65. PubMed ID: 19527451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new method for fixation and preservation of trypanosomal antigens for use in the indirect immunofluorescence antibody test for diagnosis of bovine trypanosomiasis.
    Katende JM; Musoke AJ; Nantulya VM; Goddeeris BM
    Trop Med Parasitol; 1987 Mar; 38(1):41-4. PubMed ID: 3299658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Trypanosoma brucei activity of nonprimate zoo sera.
    Black SJ; Wang Q; Makadzange T; Li YL; Van Praagh A; Loomis M; Seed JR
    J Parasitol; 1999 Feb; 85(1):48-53. PubMed ID: 10207362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-trypanosome specific components of the elevated IgM levels in rabbit trypanosomiasis.
    Mackenzie AR; Boreham PF; Facer CA
    Trans R Soc Trop Med Hyg; 1972; 66(2):344-5. PubMed ID: 5048853
    [No Abstract]   [Full Text] [Related]  

  • 37. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein.
    Raper J; Nussenzweig V; Tomlinson S
    J Exp Med; 1996 Mar; 183(3):1023-9. PubMed ID: 8642243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of irradiation on infectivity and immunogenicity of Trypanosoma brucei.
    James DM; Fregene AO; Salomon K
    J Parasitol; 1973 Jun; 59(3):489-92. PubMed ID: 4711670
    [No Abstract]   [Full Text] [Related]  

  • 39. Trypanosoma brucei genomics and the challenge of identifying drug and vaccine targets.
    Agbo EC; Majiwa PA; Büscher P; Claassen E; te Pas MF
    Trends Microbiol; 2003 Jul; 11(7):322-9. PubMed ID: 12875816
    [No Abstract]   [Full Text] [Related]  

  • 40. The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness.
    Vanhamme L; Pays E
    Int J Parasitol; 2004 Jul; 34(8):887-98. PubMed ID: 15217727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.